Neuroimaging and Neuropathology of Mucopolysaccharidosis I
Neuroimaging and Neuropathology of Mucopolysaccharidosis I
批准号:
8882119
负责人:
PATRICIA I DICKSON
金额:
$4.77万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-01 至 2018-05-31
关键词:
AdolescentAgeAnimal ModelAnisotropyApoptosisArachnoid materAtrophicBrainBrain DiseasesBrain InjuriesBrain imagingCanis familiarisCellsCerebrospinal FluidCerebrospinal Fluid PressureChildChildhoodCholesterolClinicalClinical TrialsCorpus CallosumCreation of ventriculo-peritoneal shuntDevelopmentDiffusion Magnetic Resonance ImagingDiseaseDisease MarkerEmployee StrikesEnzymesEvaluationFunctional disorderG(M3) GangliosideGangliosidesGlycosaminoglycansHumanHydrocephalusImageImpaired cognitionImpairmentInterventionLeadLearningLesionLinkLipidsLysosomal Storage DiseasesMagnetic Resonance ImagingManometryMeasurementMeasuresMethodsModelingMucopolysaccharidosesMucopolysaccharidosis IMucopolysaccharidosis I HMucopolysaccharidosis I SMyelinMyelin ProteinsNatural regenerationNerve DegenerationNeurologicNeurologic DysfunctionsNeurologic ManifestationsNeurologic SymptomsNeuronsOutcomePathogenesisPathologicPathologyPatientsProcessPrognostic MarkerRegression AnalysisResolutionRobin birdStagingStructureStudy of magneticsSymptomsTestingTimeVentricularWhite Matter Hyperintensitybasecerebral atrophycohortdysmyelinationenzyme replacement therapygray matterimprovedinfancymyelinationneuroimagingneuron apoptosisneuropathologynovelpressurepreventprotein expressionpublic health relevanceresponsetherapy developmentwhite matterwhite matter change
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose to study the relationship of neuroimaging abnormalities and neuropathology in mucopolysaccharidosis I (MPS I), a lysosomal storage disease that strikes in infancy or childhood. Children with MPS I develop hydrocephalus, atrophy, cystic or cribriform changes, and white matter abnormalities including decreased volume and fractional anisotropy of the corpus callosum (a white matter structure). The cause of hydrocephalus is thought to be decreased reabsorption of cerebrospinal fluid from storage in the arachnoid granulations, and the cause of cystic or cribriform lesions is probably the accumulation of glycosaminoglycans in perivascular (Virchow-Robin) spaces. However, the underlying basis of atrophy, white matter hyperintensities, and reduced volume and fractional anisotropy in the corpus callosum (and probably other white matter structures) is not known. The basis of these latter findings is important to understand, because they have been found to correlate with cognitive impairment in MPS patients. We hypothesize that the underlying basis of white matter abnormalities on imaging studies is dysmyelination. We have found evidence of significant dysmyelination in the corpus callosum of an MPS I animal model which is consistent with the reduced volume and fractional anisotropy in that white matter structure. The hypothesis that dysmyelination underlies these imaging findings will be directly tested, and we will also test
alternate hypotheses that gray matter disease or hydrocephalus is responsible. Methods employed will include high-resolution magnetic resonance imaging, volumetrics, diffusion tensor imaging, ultrastructural studies of white and gray matter, evaluations of myelin components, and other evaluations of gray and white matter pathology. Interventions tested will include treatment with intrathecal enzyme replacement therapy in the juvenile period and ventriculoperitoneal shunting for hydrocephalus. The results will lead to a new, central model to connect neuropathology and neuroimaging findings, which are the key to understanding the pathogenesis of MPS- related brain disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE UNDIAGNOSED DISEASES NETWORK CLINICAL SITE
-
批准号:10600550
-
项目类别:
-
资助金额:$47.62万
-
财政年份:2022
-
负责人:PATRICIA I DICKSON
-
依托单位:
Postdoctoral Training Program in Genomic Medicine
-
批准号:10642810
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2021
-
负责人:PATRICIA I DICKSON
-
依托单位:
Gene therapy with modified GlcNAc-1-phosphotransferase for mucolipidosis
-
批准号:10317695
-
项目类别:
-
资助金额:$43.31万
-
财政年份:2021
-
负责人:PATRICIA I DICKSON
-
依托单位:
Postdoctoral Training Program in Genomic Medicine
-
批准号:10426027
-
项目类别:
-
资助金额:$17.74万
-
财政年份:2021
-
负责人:PATRICIA I DICKSON
-
依托单位:
Postdoctoral Training Program in Genomic Medicine
-
批准号:10089078
-
项目类别:
-
资助金额:$7.91万
-
财政年份:2021
-
负责人:PATRICIA I DICKSON
-
依托单位:
Washington University School of Medicine Undiagnosed Diseases Network Clinical Site
-
批准号:10206222
-
项目类别:
-
资助金额:$55.0万
-
财政年份:2018
-
负责人:PATRICIA I DICKSON
-
依托单位:
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE UNDIAGNOSED DISEASES NETWORK CLINICAL SITE
-
批准号:10375221
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2018
-
负责人:PATRICIA I DICKSON
-
依托单位:
Washington University School of Medicine Undiagnosed Diseases Network Clinical Site
-
批准号:10696751
-
项目类别:
-
资助金额:$62.33万
-
财政年份:2018
-
负责人:PATRICIA I DICKSON
-
依托单位:
Washington University School of Medicine Undiagnosed Diseases Network Clinical Site
-
批准号:10872919
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2018
-
负责人:PATRICIA I DICKSON
-
依托单位:
Phenotypic effects of brain-directed enzyme therapy for Sanfilippo B syndrome
-
批准号:9000182
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2015
-
负责人:PATRICIA I DICKSON
-
依托单位:
Phenotypic effects of brain-directed enzyme therapy for Sanfilippo B syndrome
-
批准号:9234075
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2015
-
负责人:PATRICIA I DICKSON
-
依托单位:
Neuroimaging and Neuropathology of Mucopolysaccharidosis I
-
批准号:8726505
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2013
-
负责人:PATRICIA I DICKSON
-
依托单位:
The humoral immune response to recombinant enzyme in mucopolysaccharidosis I
-
批准号:8584070
-
项目类别:
-
资助金额:$6.33万
-
财政年份:2013
-
负责人:PATRICIA I DICKSON
-
依托单位:
Neuroimaging and Neuropathology of Mucopolysaccharidosis I
-
批准号:9291522
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2013
-
负责人:PATRICIA I DICKSON
-
依托单位:
Neuroimaging and Neuropathology of Mucopolysaccharidosis I
-
批准号:9084279
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2013
-
负责人:PATRICIA I DICKSON
-
依托单位:
Neuroimaging and Neuropathology of Mucopolysaccharidosis I
-
批准号:8615795
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2013
-
负责人:PATRICIA I DICKSON
-
依托单位:
The humoral immune response to recombinant enzyme in mucopolysaccharidosis I
-
批准号:8692990
-
项目类别:
-
资助金额:$6.16万
-
财政年份:2013
-
负责人:PATRICIA I DICKSON
-
依托单位:
Glycosylation-independent enzyme therapy of the brain in Sanfilippo B syndrome
-
批准号:8444050
-
项目类别:
-
资助金额:$16.57万
-
财政年份:2012
-
负责人:PATRICIA I DICKSON
-
依托单位:
Glycosylation-independent enzyme therapy of the brain in Sanfilippo B syndrome
-
批准号:8554382
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2012
-
负责人:PATRICIA I DICKSON
-
依托单位:
A STUDY OF INTRATHECAL ENZYME REPLACEMENT THERAPY FOR SPINAL CORD COMPRESSION
-
批准号:7952235
-
项目类别:
-
资助金额:$1.16万
-
财政年份:2008
-
负责人:PATRICIA I DICKSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: